Wang X Y, Hu Y J, Dong K, Zhao C, Huang X Z, Lian S Y, Sun Y
Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education), Department of Pathology, Peking University Cancer Hospital & Institute, Beijing 100142, China.
Zhonghua Bing Li Xue Za Zhi. 2020 Nov 8;49(11):1114-1119. doi: 10.3760/cma.j.cn112151-20200323-00245.
To study the clinicopathological features and PD-L1 expression of microsatellite instability-high (MSI-H) gastric cancer. The clinicopathological data of the 2 472 patients who had undergone radical surgical resection and been performed immunohistochemical staining of four major mismatch repair (MMR) proteins (MLH1, PMS2, MSH2 and MSH6) from March 2014 to December 2018 at Peking University Cancer Hospital were collected. One hundred and seventy-one patients showed mismatch repair-deficient (dMMR), and microsatellite instability of these patients were detected with polymerase chain reaction (PCR). Then, taken PCR results as the standard, PD-L1 was assessed using immunohistochemistry (IHC) in the MSI-H gastric cancers. MSI-H (vs. MSI-L) in gastric cancers was associated with female gender, advanced age, gastric-antrum location, intestinal type, lesion diameter exceeding 5 cm, absence of lymph node metastasis and positive PD-L1 expression (<0.05, respectively). Combined positive score (CPS) was an independent risk factor (=0.026, =8.385, 95%=1.293-54.367). Although no relationship between PD-L1 expression pattern and prognosis was observed,"diffuse-pattern" of the PD-L1 expression was related to lymphatic-vascular invasion (=0.007) and infiltration depth (=0.04). Among the patients with MSI-H and PD-L1 positive gastric cancer, the patients who experienced recurrence or died all had the pattern of "diffuse" PD-L1 expression. Also, regarding the expression level and staining pattern of PD-L1, the metastasis lesion of lymph node had a high coincidence with primary site (=0.45). MSI-H gastric cancer shows distinctive clinicopathological characteristics. The CPS can be used as a prognostic indicator in MSI-H gastric cancers, while the "diffuse-pattern" of PD-L1 expression could possibly be used as a prognostic indicator. The patients with advanced gastric cancer could obtain the expression level and staining pattern of PD-L1 using the biopsy material of metastatic lesions.
研究微卫星高度不稳定(MSI-H)胃癌的临床病理特征及PD-L1表达情况。收集2014年3月至2018年12月在北京大学肿瘤医院接受根治性手术切除且进行了四种主要错配修复(MMR)蛋白(MLH1、PMS2、MSH2和MSH6)免疫组化染色的2472例患者的临床病理资料。171例患者显示错配修复缺陷(dMMR),采用聚合酶链反应(PCR)检测这些患者的微卫星不稳定性。然后,以PCR结果为标准,对MSI-H胃癌患者采用免疫组化(IHC)评估PD-L1。胃癌中的MSI-H(与MSI-L相比)与女性、高龄、胃窦部位置、肠型、病变直径超过5 cm、无淋巴结转移及PD-L1表达阳性相关(P均<0.05)。联合阳性评分(CPS)是独立危险因素(P=0.026,HR=8.385,95%CI=1.293-54.367)。虽然未观察到PD-L1表达模式与预后之间的关系,但PD-L1表达的“弥漫型”与淋巴管侵犯(P=0.007)及浸润深度(P=0.04)相关。在MSI-H且PD-L1阳性的胃癌患者中,出现复发或死亡的患者均具有PD-L1表达“弥漫型”模式。此外,就PD-L1的表达水平和染色模式而言,淋巴结转移灶与原发部位具有高度一致性(P=0.45)。MSI-H胃癌表现出独特的临床病理特征。CPS可作为MSI-H胃癌的预后指标,而PD-L1表达的“弥漫型”模式可能可作为预后指标。晚期胃癌患者可利用转移灶活检材料获取PD-L1的表达水平和染色模式。
Zhonghua Bing Li Xue Za Zhi. 2020-11-8
Pathol Res Pract. 2019-3